INS and type 2 diabetes mellitus: Another case-control study, which excluded confounding effects of anti-diabetic drugs or insulin treatment, found that the methylation promoter of the TCF7L2, the gene with the strongest effect for type 2 diabetes, was significantly different between patients with type 2 diabetes and controls and associated with fasting blood glucose levels (35).